Correct me if I am wrong, but this would mean that NASH is not a viable investment space period due to the potential very early entry of a (likely) very potent generic.
Do you think this anonymous Twitter person discovered something that nobody considered before and that every analyst in every NASH company missed?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.